SUPRANE

This brand name is authorized in Austria, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug SUPRANE contains one active pharmaceutical ingredient (API):

1 Desflurane
UNII CRS35BZ94Q - DESFLURANE

Desflurane is one of a family of halogenated methyl ethyl ethers, which are administered by inhalation, producing a dose-related temporary loss of consciousness and of pain sensations, suppression of voluntary motor activity, reduction of autonomic reflexes, and depression of respiration and the cardiovascular system.

Read about Desflurane

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N01AB07 Desflurane N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AB Halogenated hydrocarbons
Discover more medicines within N01AB07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02227428
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 21.280-1-05-04
Country: EE Ravimiamet Identifier(s): 1023758, 1825332
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 60554
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 043632
Country: FR Base de données publique des médicaments Identifier(s): 65421851
Country: HK Department of Health Drug Office Identifier(s): 51461
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-368795278
Country: JP 医薬品医療機器総合機構 Identifier(s): 1119703G1024
Country: MT Medicines Authority Identifier(s): MA1277/04501
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 540M96
Country: NL Z-Index G-Standaard Identifier(s): 15959708
Country: NL Z-Index G-Standaard, PRK Identifier(s): 42471
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 7164
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100085708
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W69338001, W69338002
Country: SG Health Sciences Authority Identifier(s): 08818P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 16973021H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681413881398, 8681413881404
Country: US FDA, National Drug Code Identifier(s): 10019-641, 10019-644, 10019-646, 52584-641
Country: ZA Health Products Regulatory Authority Identifier(s): 31/2.1/0417

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.